Literature DB >> 18027037

Minimally invasive myotomy for achalasia in the elderly.

Arman Kilic1, Matthew J Schuchert, Arjun Pennathur, Rodney J Landreneau, Miguel Alvelo-Rivera, Neil A Christie, Sebastien Gilbert, Ghulam Abbas, James D Luketich.   

Abstract

BACKGROUND: Elderly patients with achalasia are more frequently being referred for minimally invasive Heller myotomy (MIM). The associated morbidity and mortality of MIM in the elderly are not well defined. The objective of this study was to review our experience with MIM in the elderly.
METHODS: We identified a total of 57 patients (32 men, 25 women) 70 years or older (mean age 78 years, range 70 to 96 years) who underwent MIM [55 laparoscopically (LAP), 2 videothoracoscopically (VATS)] for achalasia at our institution. Clinical outcomes were analyzed including postoperative surgical interventions (redo myotomy, esophagectomy), and dysphagia scores (range: 1, no dysphagia to 5, dysphagia to saliva).
RESULTS: Thirty-seven (59.6%) patients had prior endoscopic therapy. There was no perioperative mortality and median hospital stay was 3 days. There were three (5.3%) conversions to open due to adhesions and concern regarding the viability of the myotomy following repair of a small perforation. A total of 11 (19.3%) patients had complications, including three (5.3%) intraoperative esophageal perforations, three pleural effusions, one (1.8%) pneumonia, one intraoperative gastric perforation, one C. difficile infection, one ileus, and one postoperative intubation. Mean follow-up was 23.5 months. Mean dysphagia score improved from 3.38 preoperatively to 1.36 following MIM (p < 0.0001), with 55 (96.5%) patients experiencing an improvement. Reoperation for recurrent dysphagia was required in four (7.0%) of the patients.
CONCLUSIONS: MIM can be performed safely in elderly patients with achalasia in centers with significant experience in laparoscopic foregut surgery. MIM affords similar symptomatic improvement in the elderly as compared to younger patients. MIM should be seriously considered as a therapeutic strategy in elderly achalasia patients.

Entities:  

Mesh:

Year:  2007        PMID: 18027037     DOI: 10.1007/s00464-007-9657-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  29 in total

1.  Laparoscopic myotomy for achalasia: predictors of successful outcome after 200 cases.

Authors:  Alfonso Torquati; William O Richards; Michael D Holzman; Kenneth W Sharp
Journal:  Ann Surg       Date:  2006-05       Impact factor: 12.969

2.  Achalasia of the cardia.

Authors:  C W ADAMS; R H BRAIN; F G ELLIS; R KAUNTZE; J R TROUNCE
Journal:  Guys Hosp Rep       Date:  1961

3.  Laparoscopic esophageal myotomy for achalasia: factors affecting functional results.

Authors:  Subrato Deb; Claude Deschamps; Mark S Allen; Francis C Nichols; Stephen D Cassivi; Brian S Crownhart; Peter C Pairolero
Journal:  Ann Thorac Surg       Date:  2005-10       Impact factor: 4.330

4.  "Vigorous" achalasia. Its clinical interpretation and significance.

Authors:  J L Bondi; D H Godwin; J M Garrett
Journal:  Am J Gastroenterol       Date:  1972-08       Impact factor: 10.864

5.  Laparoscopic Heller myotomy with Toupet fundoplication: outcomes predictors in 121 consecutive patients.

Authors:  Yashodhan S Khajanchee; Shalini Kanneganti; Amy E B Leatherwood; Paul D Hansen; Lee L Swanström
Journal:  Arch Surg       Date:  2005-09

6.  Histopathologic features in esophagomyotomy specimens from patients with achalasia.

Authors:  J R Goldblum; T W Rice; J E Richter
Journal:  Gastroenterology       Date:  1996-09       Impact factor: 22.682

7.  Outcomes after minimally invasive esophagomyotomy.

Authors:  J D Luketich; H C Fernando; N A Christie; P O Buenaventura; R J Keenan; S Ikramuddin; P R Schauer
Journal:  Ann Thorac Surg       Date:  2001-12       Impact factor: 4.330

8.  Chest pain in achalasia: patient characteristics and clinical course.

Authors:  V F Eckardt; B Stauf; G Bernhard
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

9.  Long-term efficacy of Botulinum toxin in classical achalasia: a prospective study.

Authors:  J Kolbasnik; W E Waterfall; B Fachnie; Y Chen; G Tougas
Journal:  Am J Gastroenterol       Date:  1999-12       Impact factor: 10.864

10.  Predictors of outcome of pneumatic dilation in achalasia.

Authors:  Kaveh Farhoomand; Jason T Connor; Joel E Richter; Edgar Achkar; Michael F Vaezi
Journal:  Clin Gastroenterol Hepatol       Date:  2004-05       Impact factor: 11.382

View more
  6 in total

1.  Minimally invasive surgery for achalasia in patients >40 years: more favorable than anticipated.

Authors:  Ines Gockel; Alexandra Gith; Daniel Drescher; Florian Jungmann; Lukas Eckhard; Hauke Lang
Journal:  Langenbecks Arch Surg       Date:  2011-08-05       Impact factor: 3.445

Review 2.  Surgical treatment for achalasia: when should it be performed, and for which patients?

Authors:  Hideyuki Kashiwagi; Nobuo Omura
Journal:  Gen Thorac Cardiovasc Surg       Date:  2011-06-15

Review 3.  Major complications of pneumatic dilation and Heller myotomy for achalasia: single-center experience and systematic review of the literature.

Authors:  Kristle L Lynch; John E Pandolfino; Colin W Howden; Peter J Kahrilas
Journal:  Am J Gastroenterol       Date:  2012-10-02       Impact factor: 10.864

Review 4.  Laparoscopic Heller myotomy for achalasia: does the age of the patient affect the outcome?

Authors:  Sheraz R Markar; Giovanni Zaninotto
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

5.  Outcomes of minimally invasive myotomy for the treatment of achalasia in the elderly.

Authors:  Randall O Craft; Brenda E Aguilar; Colleen Flahive; Marianne V Merritt; Alyssa B Chapital; Richard T Schlinkert; Kristi L Harold
Journal:  JSLS       Date:  2010 Jul-Sep       Impact factor: 2.172

Review 6.  Achalasia in the Elderly: Diagnostic Approach and a Proposed Treatment Algorithm Based on a Comprehensive Literature Review.

Authors:  Amir Mari; Wisam Sbeit; Wisam Abboud; Halim Awadie; Tawfik Khoury
Journal:  J Clin Med       Date:  2021-11-26       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.